Carbidopa anhydrous
- Level
- Commodity
- Parent
- 51142500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51142549This classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula C10H14N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KR87B45RGH, chemically known as benzenepropanoic acid, .alpha.-hydrazino-3,4-dihydroxy-.alpha.-methyl-, (s)-, but more generally known as carbidopa anhydrous, which bears US NIH Compound Identifier 34359. European Medicines Agency schedules carbidopa anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06126MIG. Most nations, for tariff purposes, schedule carbidopa anhydrous under HS 29280090. Carbidopa anhydrous bears US NLM identifiers UMLS ID C1881339 and NCI Concept Code C61803. SMILES: C[C@](CC1CCC(C(C1)O)O)(C(=O)O)NN.
Same parent
Under 51142500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.